4th Jan 2011 16:28
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 December 2010, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £12.55 per Ordinary share and $39.18 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2010 to 31 December 2010:
Non Executive Director | Ordinary Shares | American Depository Shares (ADSs) |
Sir Christopher Gent | 2,689.24 | |
Prof. Sir Roy Anderson | 672.31 | |
Dr Stephanie Burns | 390.65 | |
Mr Lawrence Culp | 781.30 | |
Sir Crispin Davis | 2,490.04 | |
Sir Deryck Maughan | 781.30 | |
Mr James Murdoch | 2,091.63 | |
Dr Daniel Podolsky | 820.36 | |
Mr Tom de Swaan | 921.32 | |
Sir Robert Wilson | 672.31 |
The Company and the Non-Executive Directors were informed of these allocations on 4 January 2011.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
4 January 2011
Related Shares:
Glaxosmithkline